Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UCB0942 in adults with highly drug-resistant focal epilepsy
2014-003330-12Phase 2Completed
- Sponsor
- UCB
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Focal Onset Epilepsy comparing UCB0942 plus stable background antiepileptic drugs with Placebo plus stable background antiepileptic drugs (2 arms). Primary endpoint: 75% responder rate. Started Apr 2015; status: completed.
02
Drugs
padsevonil
03
Conditions
Focal Onset Epilepsy
Beyond the preview
Go deeper on 2014-003330-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003330-12.